Utah Medical stock hits 52-week low at $57.74 amid market shifts

Published 11/03/2025, 17:14
Utah Medical stock hits 52-week low at $57.74 amid market shifts

Utah Medical (TASE:BLWV) Products, Inc. (UTMD) stock has touched a 52-week low, dipping to $57.74, as market dynamics continue to challenge the healthcare sector. According to InvestingPro analysis, the company maintains a strong financial health score of 3.21 (rated as GREAT), with a modest P/E ratio of 14.75. The company, known for its high-quality medical devices, has experienced a notable decline over the past year, with its stock price falling by 18.49%. The company’s resilient dividend history spans 22 consecutive years, currently offering a 2.08% yield. Investors are closely monitoring UTMD’s performance as it navigates through a period of volatility, with the hope that the company’s strong fundamentals will enable a rebound from this year-long downward trend. InvestingPro analysis suggests the stock is currently undervalued, with 8 additional key insights available to subscribers.

In other recent news, Utah Medical Products has announced an increase in its quarterly dividend to $0.305 per share. This marks a 1.7% rise from the same quarter in the previous year. The dividend is set to be paid on April 3, 2025, to shareholders recorded as of March 14, 2025. The increase reflects the company’s commitment to providing value to its shareholders and indicates confidence in its financial stability and steady performance. Dividends serve as a way for companies to distribute a portion of their earnings back to shareholders, and such increases are often seen as positive signals about a company’s profitability. This development is based on a press release from Utah Medical Products, and investors typically monitor such announcements closely for implications on investment decisions. The company continues to maintain a significant presence in the healthcare market, focusing on products for women and babies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.